NCT00139568View on ClinicalTrials.gov

An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

October 31, 2005

Conditions
Constipation
Interventions
DRUG

Tegaserod

Trial Locations (1)

4056

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY